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Background. We examined whether viral dynamics in the genital tract during the natural history of acute
human immunodeficiency virus type 1 (HIV-1) infection could explain efficient heterosexual transmission of HIV.
Methods. We measured HIV-1 concentration in blood and semen samples from patients with acute and long-
term HIV-1 infection. We explored the effect of changes in viral dynamics in semen on the probability of trans-
mission per coital act, using a probabilistic model published elsewhere.
Results. Considered over time from infection, semen HIV-1 concentrations, in men with acute infection,
increase and decrease in approximate parallel with changes occurring in blood. Modeling suggests that these acute
dynamics alone are sufficient to increase probability of heterosexual transmission by 8–10-fold between peak (day
20 after infection, based on the model) and virologic set points (day 54 and later after infection). Depending on
the frequency of coitus, men with average semen HIV-1 loads and without sexually transmitted diseases (STDs)
would be expected to infect 7%–24% of susceptible female sex partners during the first 2 months of infection.
The predicted infection rate would be much higher when either partner has an STD.
Conclusions. Empirical biological data strongly support the hypothesis that sexual transmission by acutely
infected individuals has a disproportionate effect on the spread of HIV-1 infection. Acute hyperinfectiousness may,
in part, explain the current pandemic in heterosexual individuals.
The average probability of male-female transmission of
HIV-1 per unprotected coital act has been estimated,
in a large number of observational studies (reviewed
in [1, 2]), to be .0005–.0026 (1/2000–1 transmission
event/384 coital acts) during established (i.e., nonacute)
HIV-1 infection. In a study using survey-based data on
sexual behaviors in the United States, Pinkerton et al.
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[3] calculated that these probabilities of transmission
per coital act would result in low rates of lifetime trans-
mission (0.19–0.40 infected partners/man; 0.09–0.18
infected partners/woman), which, by themselves, could
not sustain an epidemic. These estimates have been
recently cited as evidence for the putative importance
of iatrogenic spread in areas where the pandemic is
growing the fastest [4]. However, most estimates of
probability of transmission per coital act used for such
calculations do not take into consideration biological
factors that might increase or decrease the probability
of transmission of HIV-1. Because the studies from
which probabilities of transmission are derived enroll
only HIV-1–discordant couples, it is important to note
that the overall estimates generated from such studies
generally reflect transmission by individuals with long-
term infection—necessarily underestimating the poten-
tial influence of transmission by acutely infected in-
dividuals with peak HIV-1 loads [5]. Transiently high
viremia could translate to heightened probability of
transmission during acute infection. Indeed, in a re-
cent study of HIV-1–serodiscordant couples in Uganda,
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Gray et al. [2] observed a strong relationship between blood
HIV-1 load and probability of heterosexual transmission.
However, that genital fluids (not blood) are the principal
vehicle for sexual transmission of HIV presents a particular
problem for modeling the likelihood of HIV transmission dur-
ing acute HIV-1 infection on the basis of blood data. This is
because acute HIV-1 infection represents the period of initial
establishment of anatomic HIV-1 reservoirs; therefore, the viral
dynamics in blood, which have been well described for acute
HIV-1 infection [6–9], cannot be assumed to apply to the gen-
ital tract. If HIV-1 load were to increase more rapidly in genital
fluids than in the systemic compartment, for instance, the prob-
ability of transmission during acute HIV-1 infection would be
greater than that predicted on the basis of concurrent blood
HIV-1 load; if, on the other hand, semen HIV-1 load were to
increase slowly, relative to blood HIV-1 load, it is possible that
no peak in probability of transmission would occur at all, de-
spite elevated blood HIV-1 load during acute HIV-1 infection.
Previous human studies examining the excretion of HIV-1 in
semen during acute HIV-1 infection have been limited by an
inability to obtain semen samples over time from untreated
patients with acute HIV-1 infection. In a study involving ex-
perimental infection of macaques with HIV type 2GB122 or sim-
ian/HIV89.6p [10], however, Pullium et al. demonstrated that
virus load peaked and subsequently declined over a similar time
frame and with similar kinetics in both semen and blood. These
data led us to hypothesize that both semen and blood HIV-1
concentrations, within an individual with acute infection, are
related by a constant ratio—that is, by a constant log differ-
ence—as they change over time.
In this report, we examine the relationship between blood and
semen HIV-1 concentrations observed in a cohort of men with
acute HIV-1 infection. We then use the observed data to develop
a predictive model of the excretion of HIV-1 in semen during
acute HIV-1 infection and to explore the effect of these dynamics
on the efficiency of heterosexual transmission of HIV-1.
PATIENTS, MATERIALS, AND METHODS
Data on Patients
Patients with acute HIV-1 infection. For preliminary de-
scriptive modeling of compartmental viral dynamics, both
blood and semen HIV-1 concentrations were available for men
with known dates of HIV-1 infection or with known dates of
onset of an acute retroviral syndrome, who had been enrolled
in the Duke-UNC-Emory Acute HIV Consortium [11] and the
GlaxoSmithKline-sponsored Quest study cohorts [12]. In-
cluded data from these cohorts were obtained at single time
points before antiretroviral therapy. Semen data were not in-
cluded for patients with evidence of concurrent sexually trans-
mitted diseases (STDs). To develop a more precise model, viral
dynamics in blood were assessed by combining blood data from
these same cohorts with additional data on blood HIV-1 con-
centrations from individuals with well-characterized acute HIV
infection that had been directly abstracted from the published
literature [9]. When the date of infection for an individual
patient was not known, the date of infection was estimated
assuming a 14-day incubation period, on the basis of previously
published data [13–16]. For all data on patients with acute
infection, blood and semen HIV-1 concentrations were ob-
tained and recorded before antiretroviral therapy, up to 1 year
after HIV-1 infection. Informed consent was obtained from all
participants; human-experimentation guidelines of the US De-
partment of Health and Human Services and/or those of all
participating authors’ institutions were followed in the conduct
of this research.
Patients with long-term HIV-1 infection. Developing the
constructed model of viral dynamics in semen required us to
estimate the distribution of semen HIV-1 concentrations for
patients with chronic HIV-1 infection at virologic set point; for
this purpose, data on semen HIV-1 load were collected from
patients with chronic HIV-1 infection enrolled in previously
published studies at the University of North Carolina at Chapel
Hill and University Hospital in St. Gallen, Switzerland [1]. Data
were included for patients who were HIV-1 antibody positive,
had CD4+ cell counts 1 200 cells/mm3, and had no documented
concurrent STDs.
HIV-1 RNA measurements. HIV-1 RNA concentrations
in semen plasma were determined by use of NucliSens HIV-1
QT (lower limit of detection, !400 copies/mL; NASBA; bio-
Merieux) [17], by use of a modification of the Roche Ultra-
sensitive reverse-transcriptase polymerase chain reaction (lower
limit of detection, !200 copies/mL), or by use of both assays.
Roche PCR was performed as follows: 500 mL of seminal plasma
was mixed with 500 mL of normal human plasma and was
centrifuged for 90 min at 50,000 g. The upper 900 mL of the
supernatant was discarded, and the pellet was resuspended in
the remaining 100 mL and used in the Roche PCR Amplicor
kit, according to the manufacturer’s descriptions. NASBA re-
sults were used for analysis when results of both assays were
available; results for the 2 assays were similar for the subset of
specimens on which both assays were run (P.L.V., unpublished
data). HIV-1 RNA concentrations in blood plasma were de-
termined by use of various commercially available assays.
Study Design
This retrospective cohort study approached the problem of the
probability of transmission of acute HIV-1 infection as follows:
1. The relationship between HIV-1 concentrations and
time was assessed in both semen and blood compartments, for
patients donating both types of samples;
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2. A precise model of viral dynamics in semen was con-
structed on the basis of longitudinally collected blood data and
a hypothesized relationship between blood and semen com-
partments (i.e., parallel compartmental dynamics)—the pre-
diction accuracy of the constructed model was then tested for
agreement with observed data on semen HIV-1 concentration;
and
3. The effect of predicted changes in viral dynamics in
semen on the probability of transmission per coital act over
time during acute HIV-1 infection was explored by combining
the constructed model of viral dynamics in semen with a prob-
abilistic model published elsewhere [1].
Statistical Methods
HIV-1 RNA measurements. Results for either compartment
(blood or semen) that were undetectable were assigned a value
that was one-half the absolute lower limit of detection for the
assay that was used and for that compartment. All HIV-1 RNA
data were then log-transformed before analysis.
Descriptive viral dynamics in semen. For patients with
concurrent blood and semen HIV-1 load values, individual ob-
servations were plotted versus the time from infection. Cor-
relation of blood and semen HIV-1 concentrations and trends
in semen HIV-1 RNA concentration over time were assessed
by use of Pearson’s correlation. Descriptive regression mod-
els on the observed semen data were compared by use of the
likelihood ratio test.
Construction of model of viral dynamics in semen. Be-
cause descriptive models were based on relatively few semen
samples obtained from study subjects before the initiation of
antiretroviral therapy, we constructed a model of viral dynamics
in semen starting with more-abundant data on blood HIV-1
concentrations in samples obtained from untreated patients
with acute HIV-1 infection: a piecewise polynomial linear
mixed model [18] with a covariance structure based on random
coefficients was first used to obtain the population average
curve for blood data. Knots for the piecewise regression were
chosen on the basis of a grid search for maximum likelihood
estimators, with peak viremia estimated to occur on day 20,
and the period of chronic infection estimated to begin on day
54. The mean HIV-1 RNA load was assumed to be 6.00 log
copies/mL on day 0, for consistency with previous reports [9].
A predictive average semen HIV-1 curve was made by adjusting
the model of viral dynamics in blood so that the predicted set
point matched the mean semen HIV-1 concentration for a
population of 42 patients with chronic HIV infection and CD4
cell counts 1200 cells/mm3. The prediction accuracy of the final
constructed model was assessed in terms of agreement between
predicted and observed values, as measured by the number of
observed data points falling within prediction bands around
the predicted population curve in the final constructed model.
Estimation of probability of transmission for hypothetical
partnerships during acute HIV-1 infection. To estimate the
effect of changes in semen HIV-1 load on an individual’s in-
fectiousness during acute infection, probabilities of male-female
transmission per coital act were calculated from predicted se-
men HIV-1 RNA load values, for hypothetical partnerships, by
use of a probabilistic model published elsewhere [1]. As put
forth by Chakraborty et al. [1], this model based estimates of
probability of transmission per coital act on rates observed
among HIV-serodiscordant couples and on an assumption that,
for any individual partnership, this probability was primarily
determined by the absolute R5 HIV-1 count per ejaculate, for
the male partner, and by the CCR5+ cervicovaginal receptor-
cell density, for the susceptible female partner. By reconciling
distributions for these parameters, which were observed in clin-
ical studies, with observed transmission rates, Chakraborty et
al. were able to estimate the effects of varying either parameter
on the probability of transmission within hypothetical part-
nerships. To do the same, using the present data, we estimated
inputs to the model of Chakraborty et al., assuming 100% R5
HIV-1 in semen during acute infection, 70% R5 in semen for
patients with chronic infection [19], a median ejaculate volume
of 2.30 mL [1], and a median cervicovaginal receptor-cell den-
sity of 184.8 CCR5+ cells/mm3 [20]. Predicted semen HIV-1
curves were generated by adjusting the curve from the con-
structed model on viral dynamics in semen to match (at day
54) R5 HIV-1 counts in semen for representative men at set
point. The estimated probability of transmission for partner-
ships including these men were then plotted versus the time
from infection. Probabilities of transmission within partner-
ships in which the partners had different frequencies of un-
protected coitus during the period from day 0 to day 54 were
calculated assuming regular coitus at evenly spaced intervals,
beginning on day 0.
RESULTS
Excretion of HIV-1 in semen during acute infection. To
assess the dynamics of the excretion of HIV-1 in semen during
acute HIV-1 infection, we examined concurrent blood and se-
men HIV-1 RNA concentrations in samples from 30 men with
acute HIV-1 infection participating in 2 large, acute-infection
cohorts. All semen samples from subjects with acute infection
were donated 14–84 days (median, 38 days) after the estimated
date of infection. Semen HIV-1 RNA concentrations were sim-
ilar between cohorts. Overall, in samples from men with acute
infection, semen HIV-1 RNA concentrations (mean  SD,
log copies/mL) were significantly higher than those4.1 1.14
in samples from a comparison group of 42 antiretroviral treat-
ment–naive men with chronic HIV-1 infection (mean  SD,
log copies/mL) ( ). Semen HIV-1 RNA con-3.49 1.28 Pp .04
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Figure 1. Regression model on semen data. Concurrent, pre-antiret-
roviral-therapy HIV-1 concentrations in semen (black circles) and blood
(white circles) are shown plotted vs. the estimated time from infection,
for men with acute HIV-1 infection without sexually transmitted diseases
( ). A cubic regression model on observed semen HIV-1 concen-np 30
tration data (solid black line) is shown, along with its 95% confidence
intervals (interrupted black line).
Figure 2. Population average curve for longitudinal blood data. The average fitted curve (heavy black line) for the longitudinal HIV-1 load measurements
( ) was obtained by use of a piecewise polynomial linear mixed model. Its 95% confidence intervals are shown by the thinner black lines.np 171
Longitudinal data for each patient ( ) are displayed in gray.np 53
centrations determined close to the time of the onset of symp-
toms were significantly higher than those determined later dur-
ing acute infection ( ). The fitted cubic regression curveP ! .01
for the semen data (figure 1) closely resembled the form of
previously published models [6–9] describing viral dynamics
in blood; this curve had a statistically significantly better fit
than did the alternate quadratic regression curve ( ).P ! .0001
In addition, we found that acute-infection blood and semen
HIV-1 concentrations were significantly correlated over time,
despite a likely rapid flux in these measurements within indi-
viduals (Pearson’s correlation, 0.37; ).Pp .04
Modeling viral dynamics in semen. Although these cross-
sectional data suggested similar dynamics in blood and semen,
the resultant descriptive model had insufficient prediction ac-
curacy to allow estimation of the dynamics of the probability
of transmission. However, we had access to abundant, longi-
tudinally obtained blood data, which we used to develop a more
precise model of viral dynamics in semen. We reasoned that,
if the relationship between blood and semen HIV-1 concen-
trations were relatively constant within each individual in a
population during acute infection, then the scatter of semen
HIV-1 concentrations plotted versus time, for a population,
would parallel changes in blood plasma viremia in the same
population. We therefore constructed a predictive model of
viral dynamics in semen, from blood data, assuming the hy-
pothesized relationship, and then assessed the prediction ac-
curacy of this constructed model in terms of agreement between
predicted and observed semen HIV-1 RNA load values, fol-
lowing a paradigm frequently used to study population phar-
macokinetics. A blood curve representing mean log10 HIV-1
RNA concentration was constructed on 171 longitudinal blood
HIV-1 concentration data points, for 53 patients (mean follow-
up, 12.4 days; median follow-up, 1 day; range, 1–80 days), by
use of piecewise polynomial regression (figure 2) [18]. This
curve demonstrated an initial rapid increase in blood HIV-1
load, reaching an estimated average peak HIV-1 RNA load of
5.93 log copies/mL at day 20 after infection (6 days after onset
of symptoms, for patients with an acute retroviral syndrome)
and declining to 4.74 log copies/mL by day 54 (day 40 after
onset of symptoms). Assuming parallel dynamics in blood and
semen, we constructed a predictive average semen probabilities
curve by adjusting the model of viral dynamics in blood so
that the predicted set point matched the mean semen HIV-1
concentration for patients with chronic HIV-1 infection and
CD4 cell counts 1200 cells/mm3. Finally, we measured the pre-
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Figure 3. Observed and predicted semen HIV-1 RNA distributions.
Semen plasma HIV-1 RNA concentrations (black circles) are superimposed
on a prediction band representing the constructed model on viral dynamics
in semen. Prediction bands were defined by adjusting the average fitted
blood curve so that predicted values at day 54 (virologic set point) matched
a distribution of semen HIV-1 concentrations in men with long-standing
HIV-1 infection ( ). The band shown here is defined by the predictednp 42
population SD.mean 1
Figure 4. Calculated probabilities of transmission per coital act over
time. Calculated probabilities of transmission for hypothetical partnerships
involving a female partner of average susceptibility are shown, as they
change over time, for 3 representative individuals with acute HIV-1 in-
fection. Viral dynamics in semen were assumed to follow those of the
constructed model on viral dynamics in semen, adjusted to match the
position of a given individual in the distribution of semen HIV-1 load
values at day 54 among men with long-standing HIV-1 infection. Cal-
culated probabilities for individuals at the 25th (black), 50th (dark gray),
and 75th (light gray) percentile semen HIV-1 load values are shown,
assuming fixed, average partner susceptibility.
diction accuracy of the constructed model by calculating the
number of semen HIV RNA values from the primary infection
cohorts that fell within prediction bands around the predicted
population curve (figure 3). Predictions of the constructed
model of viral dynamics in semen were in excellent agreement
with the distribution of timed semen HIV-1 concentrations:
77% of semen HIV-1 load values were within 1 SD of the
predicted population mean, on the basis of the distribution of
set-point concentrations for patients with chronic HIV-1 in-
fection. Altering the assigned value for initial inoculum by 100-
fold (i.e., by 2.0 log) in either direction had a minimal (con-
sistently !11%) effect on peak and set-point HIV-1 load
estimates generated by the model. Changing this parameter had
no effect on the prediction accuracy of the constructed model.
An alternative model, imposing a shift of 14 days in the time
to peak HIV RNA level between blood and semen, showed
lesser agreement with observed semen HIV-1 load values.
Dynamics of the probability of transmission. To better
understand the effect of the changes in semen HIV-1 load pre-
dicted by our constructed model of viral dynamics in semen
on an individual’s infectiousness during acute infection, we
used the previously published probabilistic model of Chakra-
borty et al. [1], treating male-female sexual transmission of
HIV-1 as a function of R5 HIV-1 count in an ejaculate and
CCR5+ receptor-cell density in cervicovaginal tissues. We ex-
plored the effect of varying semen HIV-1 concentrations on
the probability of transmission in a hypothetical partnership.
By assuming the accuracy of the constructed model of viral
dynamics in semen, we generated predicted semen HIV-1
curves for men with representative semen HIV-1 concentrations
at day 54. We then derived estimates of the dynamics of the
probability of transmission, assuming average susceptibility in
a hypothetical partner (figure 4). We estimated that, at the time
of peak viremia predicted by our constructed model (day 20
after infection), the probabilities of transmission per coital act,
for individuals at the 25th, 50th, and 75th percentiles of the
observed distribution of semen values for men at set point,
were 1/1099, 1/213, and 1 transmission event/53 coital acts,
respectively (table 1). For calculations of the probabilities of
transmission within hypothetical partnerships in which the
partners had different frequencies of unprotected coitus during
the period from day 0 to day 54, we assumed average suscep-
tibility of the partner, no change in the susceptibility of the
partner during this time, and regular coitus at evenly spaced
intervals, beginning on day 0. The probabilities of transmission
within stable partnerships, assuming 8 coital acts/month over
the course of 54 days of infection, were 0.6%, 3.2%, and 12.4%,
respectively, for the same categories of individuals as above.
DISCUSSION
The present study has provided empirical evidence that men
with acute HIV-1 infection are biologically hyperinfectious be-
cause of increased genital shedding of HIV-1. In addition, the
present study has provided evidence that, during acute infec-
tion, HIV-1 load increases and decreases in semen in approx-
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Table 1. Calculated probabilities of HIV-1 transmission for susceptible female partners of men with acute HIV-1 infection.
Semen HIV-1
RNA concentration
percentile, days
from infection
Semen HIV-1 RNA
concentration,
log10 HIV-1 RNA
copies/mL
Point estimate of
probability of HIV-1
transmission/coital act
(95% confidence bound)
Estimated
odds of HIV-1
transmission/
coital act
Fold change
(day 20–54)
Probability of transmission
during acute phase (day 0–54)
in a partnership with a given
frequency of unprotected coitus
4 acts/
month
8 acts/
month
16 acts/
month
75th
20 5.19 0.019 (.009, .041) 1:53 8.3 0.065 0.124 0.232
54 4.00 0.0023 (.0013, .0038) 1:435
50th
20 4.40 0.0047 (.0022, .00996) 1:213 8.5 0.016 0.032 0.062
54 3.21 0.00055 (.00032, .00092) 1:1818
25th
20 3.49 0.00091 (.00042, .00195) 1:1099 9.1 0.003 0.006 0.012
54 2.30 0.0001 (.00006, .00018) 1:10,000
imate parallel with changes occurring in blood, which have
been well described. Our present model of viral dynamics in
semen suggests that, on average, individuals are hyperinfectious
beginning before the onset of the acute retroviral syndrome
and continuing for ∼6 weeks thereafter.
In a study of discordant couples in Uganda, Gray et al. [2]
provided compelling evidence that blood HIV-1 load influences
the probability of heterosexual transmission; Chakraborty et al.
[1] developed a model to predict the transmission of HIV-1
from an infected man to his female partner on the basis of
semen HIV-1 concentration, and the predictions of that model
were in close agreement with the empirical results from the
study of couples in Uganda. In the present study, we used this
probabilistic model to examine the effect of excretion of HIV-
1 in semen during acute HIV-1 infection on sexual transmis-
sion, for a given population. We focused specifically on a pop-
ulation of men with clade-B HIV-1 infection who had no
evidence of other STDs. For an average individual in this pop-
ulation, the results suggested a very high average probability
of heterosexual transmission (0.0047 or 1 transmission event/
213 coital acts), ∼20 days into acute infection. These men would
be expected to transmit virus to 2%–6% of female sex partners
during the first 2 months of infection. These data contrast with
very low rates projected for this population on the basis of
probabilities seen in established infection [3]. Of importance,
men in sub-Saharan Africa with clade-C HIV-1 infection have
3–4-fold higher semen HIV-1 loads [21], even without STD
coinfection. Assuming no STDs for either the index patient or
the partner, an average man with acute HIV-1 infection in sub-
Saharan Africa would, conservatively, infect 7%–24% of female
sex partners during the first 2 months of infection. In part-
nerships in which either partner had an STD, this rate could
exceed 50%.
All these estimates of the probability of transmission during
acute infection should be considered as minimal estimates, for
several additional reasons. First, average fitted curves for pop-
ulations tend to blunt individual peak values when individual
curves are asynchronous—which is almost certainly the case
in patients in our study and, hence, in our final constructed
model. Second, overall, genital fluid HIV-1 inoculum is only
1 potentially important biological determinant of individual
infectiousness. A given inoculum of HIV-1 may be expected to
have higher infectious potential during acute infection, since
early variants (typically R5) are very homogeneous in env and
are closely related to successfully transmitted strains. The ab-
sence of antibodies to HIV-1 in infectious body fluids early
during acute infection might also increase the potential of trans-
mission. Third, other factors related to increased susceptibility
of the partner (e.g., frequent genital ulceration or absence of
acquired mucosal immunity [22–24]) or high rates of partner
change and riskier modes of sexual interaction [25] would be
expected to amplify the effect of increased infectiousness during
acute HIV-1 infection on probability transmission and spread
within sexual networks [26].
A number of lines of epidemiologic evidence suggest that
acute infection fuels heterosexual spread of HIV-1. Both look-
back studies examining transmission rates [27, 28] and case
series documenting rapid secondary transmission [13, 29] have
suggested an elevated risk of transmission per coital act, relative
to chronic infection. In addition, mathematical modeling stud-
ies [26] and evidence of extensive case-clustering among acutely
infected patients [29] have demonstrated that acute HIV-1 in-
fection may play an important role in the pandemic.
The present study used cross-sectional data and cannot ac-
count for possible selection bias with regard to the time samples
were obtained from patients. It is also not possible to completely
evaluate the influence of potential confounders, such as STDs
or differences in viral subtype or phenotype, in the study pop-
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ulation. In addition, patients with symptomatic, acute HIV-1
infection may have higher than average blood HIV-1 loads;
however, in the present study, higher blood HIV-1 load values
would not necessarily lead to overestimation of the probability
of transmission, given the way that our particular model was
constructed. Moreover, the present study’s weaknesses are
counterbalanced by important strengths. By pooling longitu-
dinally collected blood data from multiple studies, we were able
to develop a model of viral dynamics for a population, with
precision and predictive power. The hypothesis-driven statis-
tical approach that we used to assess viral dynamics in semen
in the present study may have promise in assessing other clinical
situations and difficult-to-sample tissue compartments, such as
the female genital tract or the central nervous system. Finally,
the present study directly relates measured changes in genital
HIV-1 shedding to probability of transmission, by use of the
empirically derived model of Chakraborty et al. [1]. The pro-
jections derived from the model of Chakraborty et al., on the
basis of our estimates of viral dynamics in semen, cannot ac-
count for the influence of variations in the susceptibility of
female partners; nonetheless, the ability to estimate the effect
of measurable biological phenomena on the probability of HIV-
1 transmission is a powerful tool that could be useful in mod-
eling HIV-1 prevention strategies. In particular, the observation
that, in the absence of STDs, viral dynamics in blood during
acute HIV infection may accurately reflect viral dynamics in
the genital tract allows more-confident exploration of the effects
of interventions early during HIV disease on transmission in
populations.
Only a small number of the estimated 40,000 acute HIV-1
infections that occur annually in the United States [30] are
diagnosed, and there are few specific public health systems in
place to facilitate identification or management of the syn-
drome. It has been assumed that, because of the brevity of
acute infection, individuals with acute infection would make a
minor contribution to the epidemic. However, the efficiency
of transmission predicted by the present study forces recon-
sideration of such assumptions and underscores acute HIV-1
infection as a unique public health opportunity [31]. This may
be particularly true in sub-Saharan Africa. Public health inter-
ventions directed at acutely infected individuals, including safe-
sex counseling, condom promotion, and antiretroviral therapy,
can decrease sexual infectivity to the extent that sexual practices
are altered and/or HIV-1 load is reduced over time. These effects
are maximized when introduced early during infection and at a
time of high transmission potential. The potential clinical benefits
[32] of acute antiretroviral treatment for individual patients who
are diagnosed during antibody-negative acute infection further
emphasize the need for improved and early identification of cases
of HIV-1 infection. Treatment considerations for recent sex con-
tacts should include both prospective screening for acute and
chronic HIV infection and appropriate screening for other sex-
ually transmitted pathogens. An estimated average probability of
sexual transmission of 1 transmission event/213 coital acts—a
risk of HIV-1 acquisition similar to that associated with percu-
taneous blood exposures in the setting of chronic HIV-1 infection
[33]—may further warrant rapid identification and notification
of potentially exposed partners, with possible provision of post-
sexual-exposure prophylaxis.
The benefits potentially associated with diagnosis of acute
HIV-1 infection are likely to be greatest if cases of infection
are identified around the period of peak viremia, a circumstance
that is, at present, rare. Public health strategies that may aid
in the identification of early acute infections include incor-
porating pooling and nucleic acid screening into routine HIV-
1 testing [34] and developing more-effective acute HIV-infec-
tion referral networks [12]. These efforts may make it possible
to implement a proactive response to prevention of transmis-
sion by patients with acute HIV-1 infection and to facilitate
these patients’ early entry into care.
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